3’-去叔丁氧羰基氨基-3’-[3-(5,5-二甲基-2,4-二酮基-1,3-恶唑烷基)]-7,10-O-双{[(2,2,2-三氯乙基)氧]羰基}多烯紫杉醇
3’-去叔丁氧羰基氨基-3’-[3-(5,5-二甲基-2,4-二酮基-1,3-恶唑烷基)]-7,10-O-双{[(2,2,2-三氯乙基)氧]羰基}多烯紫杉醇
多西他赛代谢物中间体;多烯紫杉醇代谢物中间体;3’-去叔丁氧羰基氨基-3’-[3-(5,5-二甲基-2,4-二酮基-1,3-恶唑烷基)]-7,10-O-双{[(2,2,2-三氯乙基)氧]羰基}多烯紫杉醇
3’-De-tert-butoxycarbonylamino-3’-[3-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidinyl)] -7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel
多西他赛代谢物中间体;多烯紫杉醇代谢物中间体;3’-去叔丁氧羰基氨基-3’-[3-(5,5-二甲基-2,4-二酮基-1,3-恶唑烷基)]-7,10-O-双{[(2,2,2-三氯乙基)氧]羰基}多烯紫杉醇
3’-De-tert-butoxycarbonylamino-3’-[3-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidinyl)] -7,10-O-bis{[(2,2,2-trichloroethyl)oxy]carbonyl} Docetaxel
-
产品编号: CDR209700
-
CAS号: 160651-94-5
-
分子式:C49H51Cl6NO19
-
分子量:1170.64
英文别名:
[2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]- α-Hydroxy-5,5-dimethyl- 2,4-dioxo-β-phenyl-3-Oxazolidinepropanoic Acid 12b-(Acetyloxy)-12-(benzoyloxy) -2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-11-hydroxy-4a,8,13,13-tetramethyl-5-oxo-4,6-bis[[(2,2
可溶性:
Dichloromethane, Ethyl Acetate, Methanol
参考文献:
Commercon, A., et al.: Tetrahedron, 50, 10289 (1994),
An intermediate in partial synthesis of major human metabolites of Docetaxel (D494420), an antineoplastic.
搜索质检报告(COA)
搜索MSDS